Quanta Inc (fka QNTA)

[JediMozart]

Conference Call Topics:

? Potential investment infusion;
? Further developments on FDA Pre-IND application #150335 for Escozine as a COVID-19 treatment;
? Lobbying to the FDA;
? Update on Dominican Republic controlled double-blind clinical strategy for Escozine as a COVID-19 treatment;
? Mexico importation and distribution of Escozine, and clinical strategy and preparation for a study on Escozine as a COVID-19 treatment;
? The Company’s name and stock symbol change status;
? Changes to the Company’s executive management and corporate control;
? Additional distribution opportunities;
? Implementation of new sales and marketing strategies;
? Collaborative opportunities with large pharmaceutical companies;
? Change in the Company’s independent auditing firm;
? Addressing recent concerns from shareholders;